Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-1...
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
AbstractSARS-CoV-2 has ushered a global pandemic with no effective drug being available at present. Although several FDA-approved drugs are currently under clinical trials for drug repositioning, there is an on-going global effort for new drug identification. In this paper, using multi-omics (interactome, proteome, transcriptome, and bibliome) data...
Alternative Titles
Full title
Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7547373
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7547373
Other Identifiers
ISSN
0010-4825
E-ISSN
1879-0534
DOI
10.1016/j.compbiomed.2020.104051
